Doxorubicin resistance in breast cancer is driven by light at night‐induced disruption of the circadian melatonin signal

Publisher: John Wiley & Sons Inc

E-ISSN: 1600-079x|59|1|60-69

ISSN: 0742-3098

Source: JOURNAL OF PINEAL RESEARCH (ELECTRONIC), Vol.59, Iss.1, 2015-08, pp. : 60-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content